Studies on the Defect Which Causes Absence of Decay Accelerating Factor (DAF) from the Peripheral Blood Cells of an Individual with the Inab Phenotype

Overview

Journal Biochem J

Specialty Biochemistry

Date 1989 Jul 15

PMID 2476116

Citations 7

Authors

C G Tate

M Uchikawa

M J Tanner

P A Judson

S F Parsons

G Mallinson

D J Anstee

Affiliations

Soon will be listed here.

Abstract

1. We have studied the peripheral blood cells of an individual with the Inab phenotype who is deficient in decay accelerating factor (DAF). 2. In contrast with the situation in paroxysmal nocturnal haemoglobinuria, membranes from peripheral blood cells of the Inab phenotype individual lack DAF, but retain the other glycosylphosphatidylinositol-linked proteins acetylcholinesterase and LFA-3. 3. Unlike normal Epstein-Barr-virus-transformed lymphoblastoid cell lines (EBV-LCL), DAF was not expressed on EBV-LCL derived from peripheral blood lymphocytes of the Inab individual. 4. No differences in the DAF gene of normal and Inab phenotype individuals could be detected by Southern blotting studies. 5. EBV-LCL derived from the Inab individual had a gross reduction in the level of DAF mRNA compared with normal EBV-LCL. 6. Our results suggest that the DAF gene in the Inab phenotype contains a mutation which affects the transcription or processing of DAF mRNA.

Citing Articles

Laboratory studies for paroxysmal nocturnal hemoglobinuria, with emphasis on flow cytometry.

Lima M Pract Lab Med. 2020; 20:e00158.

PMID: 32195308 PMC: 7078534. DOI: 10.1016/j.plabm.2020.e00158.

CD55 is over-expressed in the tumour environment.

Li L, Spendlove I, Morgan J, Durrant L Br J Cancer. 2001; 84(1):80-6.

PMID: 11139317 PMC: 2363604. DOI: 10.1054/bjoc.2000.1570.

Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin.

Brodsky R, Mukhina G, Li S, Nelson K, Chiurazzi P, Buckley J Am J Clin Pathol. 2000; 114(3):459-66.

PMID: 10989647 PMC: 4124633. DOI: 10.1093/ajcp/114.3.459.

Therapeutic uses of recombinant complement protein inhibitors.

Kalli K, Hsu P, Fearon D Springer Semin Immunopathol. 1994; 15(4):417-31.

PMID: 8153875 PMC: 7101590. DOI: 10.1007/BF01837368.

Membrane proteins that protect against complement lysis.

Morgan B, Meri S Springer Semin Immunopathol. 1994; 15(4):369-96.

PMID: 8153873 DOI: 10.1007/BF01837366.

References

Chirgwin J, Przybyla A, MacDonald R, Rutter W . Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979; 18(24):5294-9. DOI: 10.1021/bi00591a005. View

SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

Nicholson-Weller A, Burge J, Fearon D, Weller P, Austen K . Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol. 1982; 129(1):184-9. View

Daniels G, Tohyama H, Uchikawa M . A possible null phenotype in the Cromer blood group complex. Transfusion. 1982; 22(5):362-3. DOI: 10.1046/j.1537-2995.1982.22583017458.x. View

Pangburn M, Schreiber R, TROMBOLD J, MULLER-EBERHARD H . Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes. J Exp Med. 1983; 157(6):1971-80. PMC: 2187048. DOI: 10.1084/jem.157.6.1971. View

Anstee D, Ridgwell K, Tanner M, Daniels G, Parsons S . Individuals lacking the Gerbich blood-group antigen have alterations in the human erythrocyte membrane sialoglycoproteins beta and gamma. Biochem J. 1984; 221(1):97-104. PMC: 1144007. DOI: 10.1042/bj2210097. View

Mallinson G, Martin P, Anstee D, Tanner M, Merry A, Tills D . Identification and partial characterization of the human erythrocyte membrane component(s) that express the antigens of the LW blood-group system. Biochem J. 1986; 234(3):649-52. PMC: 1146620. DOI: 10.1042/bj2340649. View

Caras I, Davitz M, Rhee L, WEDDELL G, Martin Jr D, NUSSENZWEIG V . Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature. 1987; 325(6104):545-9. DOI: 10.1038/325545a0. View

Medof M, Lublin D, Holers V, Ayers D, Getty R, Leykam J . Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci U S A. 1987; 84(7):2007-11. PMC: 304572. DOI: 10.1073/pnas.84.7.2007. View

10.

Rey-Campos J, Rubinstein P, Rodriguez de Cordoba S . Decay-accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans. J Exp Med. 1987; 166(1):246-52. PMC: 2188646. DOI: 10.1084/jem.166.1.246. View

11.

Selvaraj P, Dustin M, Silber R, Low M, Springer T . Deficiency of lymphocyte function-associated antigen 3 (LFA-3) in paroxysmal nocturnal hemoglobinuria. Functional correlates and evidence for a phosphatidylinositol membrane anchor. J Exp Med. 1987; 166(4):1011-25. PMC: 2188732. DOI: 10.1084/jem.166.4.1011. View

12.

Spring F, Judson P, Daniels G, Parsons S, Mallinson G, Anstee D . A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets. Immunology. 1987; 62(2):307-13. PMC: 1453983. View

13.

Stafford H, Tykocinski M, Lublin D, Holers V, Rosse W, Atkinson J . Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells. Proc Natl Acad Sci U S A. 1988; 85(3):880-4. PMC: 279660. DOI: 10.1073/pnas.85.3.880. View

14.

Tanner M, High S, Martin P, Anstee D, Judson P, Jones T . Genetic variants of human red-cell membrane sialoglycoprotein beta. Study of the alterations occurring in the sialoglycoprotein-beta gene. Biochem J. 1988; 250(2):407-14. PMC: 1148871. DOI: 10.1042/bj2500407. View

15.

Telen M, Hall S, Green A, Moulds J, Rosse W . Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med. 1988; 167(6):1993-8. PMC: 2189670. DOI: 10.1084/jem.167.6.1993. View

16.

Lin R, Herman J, Henry L, Daniels G . A family showing inheritance of the Inab phenotype. Transfusion. 1988; 28(5):427-9. DOI: 10.1046/j.1537-2995.1988.28588337329.x. View

17.

Ellman G, CALLAWAY E . Erythrocyte cholinesterase-levels in mental patients. Nature. 1961; 192:1216. DOI: 10.1038/1921216a0. View

18.

Aviv H, Leder P . Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci U S A. 1972; 69(6):1408-12. PMC: 426713. DOI: 10.1073/pnas.69.6.1408. View

19.

Marsh W . Scoring of hemagglutination reactions. Transfusion. 1972; 12(5):352-3. DOI: 10.1111/j.1537-2995.1972.tb04459.x. View

20.

Humphries S, Whittall R, Minty A, Buckingham M, Williamson R . There are approximately 20 actin gene in the human genome. Nucleic Acids Res. 1981; 9(19):4895-908. PMC: 327487. DOI: 10.1093/nar/9.19.4895. View